Page last updated: 2024-10-27

fluconazole and Neoplasm Regression, Spontaneous

fluconazole has been researched along with Neoplasm Regression, Spontaneous in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Neoplasm Regression, Spontaneous: Disappearance of a neoplasm or neoplastic state without the intervention of therapy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, AT1
Dhorajiya, P1
Lung, E1

Other Studies

1 other study available for fluconazole and Neoplasm Regression, Spontaneous

ArticleYear
A rapidly regressive esophageal squamous papilloma.
    Gastrointestinal endoscopy, 2019, Volume: 90, Issue:4

    Topics: Anti-HIV Agents; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophageal Neoplasms; Fluconaz

2019